Global International Medical Director
Novo Nordisk Inc.
Watertown, Massachusetts, United States
Professional Expierences:
current - 2022 Medical Director NovoNordisk Inc. (former Forma Therapeutics)
2020-2022 Associate Director, Program in Pediatric Health Equities Research. , Johns Hopkins All Children’s Hospital, St. Petersburg, FL
2017-2022 Director, Comprehensive Sickle Cell Program, Cancer and Blood Disorders Institute, Johns Hopkins All Children’s Hospital, St. Petersburg,
FL
2017-2022 Assistant Professor, Department of Pediatrics, Johns Hopkins School of Medicine
2019-2021 Division Chief, Hematology, Cancer and Blood Disorders Institute, Johns Hopkins All Children’s Hospital, St. Petersburg, FL
2013-2017 Assistant Professor, Departments of Pediatrics and Internal Medicine Division of Hematology and Oncology, Augusta University, Member,
GRU Cancer Center
2013-2017 Director, Sickle cell disease transition program, Augusta University Sickle Cell Center Augusta University
Education:
2000 Bachelor of Arts (BA) - New York University
2006 Medical Doctorate (MD) - Morehouse School of Medicine
2016 Master of Clinical and Translational Science (MCTS) - Augusta University
Additional Skills, Training, & Memberships
Training
Postdoctoral (Internship, residency, fellowship, etc.)
2006-2010 Internship/Residency, Internal Medicine and Pediatrics, Rutgers, New Jersey Medical School Newark, NJ
2010-2013 Fellowship, Pediatric Hematology Oncology. University of North Carolina, Chapel Hill, NC
Certification
Medical, other state/government licensure
2017 – Current State of Florida Medical License, #ME 134439l
2017 – 2020 State of Massachusetts Medical License, #273145
2013 – 2021 State of Georgia Medical License, #070499
2010 – 2013 State of North Carolina Medical License, #2010-00849
Boards, other specialty certification
2016 Board-Certified in General Pediatrics, ABP Certificate #11654
2022 Board Eligibility in Pediatric Hematology Oncology, ABP #678709
2020 Board Not-Certified in Internal Medicine, ABIM #299195
2017 – Current DEA Registration: FJ7235814
2010 – Current DEA Registration: FC2828551
2010 – Current National Provider Identification: 1821249202
2012 – Current Advanced Cardiovascular Life Support Provider
2009 – Current Pediatric Life Support Provider, Recertification
2004 – 2007 United States Medical Licensing Exam (USMLE) Certified
2009 – 2013 Neonatal Advanced Life Support Provider
Professional Societies
2003-2006 Student National Medical Association, Member
2013-2017 Medical Director, Sickle Cell Foundation of Georgia
2014-2016 Georgia Chapter, American Academy of Pediatrics, Sickle Cell Disease Champion
2012-2018 Sickle Cell Provider’s Network Jr (SCPNJR), Member
2013-2018 Sickle Cell Foundation of Georgia, Medical Director
2012-2018 Southeastern Regional Consortium, GRU Representative, member
2014-2018 National Coordinating Center Transition Workgroup, member
2006-Present National Medical Association, Member
2006-Present American Academy of Pediatrics, Member
2006-Present American Medical Association, Member
2007-Present American College of Physician, Member
2008-Present NOAH NY, SUNY Downstate, Member
2010-Present American Society of Pediatric Hematology/Oncology Children’s Oncology Group, Member
2011-Present American Society of Hematology, Active Member
2011-Present Sickle Cell Adult Provider’s Network (SCAPN), Member, Secretary (2020)
2011-Present EE Just Medical Society, Lifetime Member, Secretary (2017-2019); Treasurer (2019-present)
2011-Present Durham Academy of Medicine, Dentistry, and Pharmacy (Durham-Chapel Hill NMA), Member
2013-Present Hemostasis and Thrombosis Research Society Clinical Fellow’s Network, Member
2018-Present Florida Chapter of American Academy of Pediatrics, Member, Membership Co-Char (2019)
Research & Publications
Original Research
1. E. Leila Jerome Clay, MD, Julia Brittain, PhD, Rupa Redding-Lallinger, MD Blood (2012) 120 (21): 4768.
Vitamin Deficiency, CD40L and VEGF in a Young Population with Sickle Cell Disease DOI: https://doi.org/10.1182/blood.V120.21.4768.4768
2. Makala L, Torres C, Clay EL, Neunert C, Pace B. Fetal Hemoglobin Induction to Treat bHemoglobinopathies: From Bench to Bedside. J Hematol Transfus. 2014; 2(2): 1018.
3. Clay ELJ, Motsinger-Reif A, Hoskins J, Veit L, Calikoglu A and Redding-Lallinger R. The Polymorphisms in the Vitamin D Receptor Gene and Disease Severity in Sickle Cell Disease. Advances in Biological Chemistry. 2015; 5:24-33.
4. Clay ELJ, Burrell T, Belhorn T, Redding-Lallinger R. Immunogenicity of pneumococcal vaccination in a patient with sickle hemoglobinopathy: a case report. Clinical Case Reports. 2015; DOI: 10.1002/ccr3.276
5. Wilder C, George N, Xu H, Clay ELJ. Sickle Cell Disease Transition Assessment and Readiness: A Baseline Analysis. Journal of Sickle Cell Disease and Hemoglobinopathy, Volume III April 15, 2016
6. Clay, ELJ, Hsu G, Jordan L. Xu H and Pace BS. A survey of Pneumococcal Prophylaxis Practices among Sickle Cell Providers. J Pediatr & Child Health Care. 2016; 1(1):1005.
7. Julia Brittain, E. Leila Jerome Clay, Ryan Harris, Itia Lee, Abdullah Kutlar and Sanjiv Kumar. Vitamin D Repletion Mitigates Oxidative Stress Induce Pulmonary Artery Remodeling in Sickle Cell
Disease Blood 2017 130:443 https://doi.org/10.1182/blood.V130.Suppl_1.443.443
9. Ofelia A. Alvarez, MD, Sandra Echenique, Hector Rodriguez-Cortes, MD, Thomas J. Harrington, MD, E. Leila Jerome Clay, MD MCTS, FAAP, Vandy Black, MD MSc, Mary Murph, Christopher Wells, Ifeyinwa Osunkwo, MDMPH, Blood (2019) 134 (Supplement_1): 5862. https://doi.org/10.1182/blood-2019-123215
10. Elizabeth Williams, BA, Elizabeth Brown, Deepa Manwani, MD, Payal Desai, MD, Joshua J. Field, MD, Lynne D. Neumayr, Susan Padrino, MD, E. Leila Jerome Clay, MD MCTS, FAAP, Ze Cong, PhD, Irene Agodoa, MD, Carolyn Hoppe, MD, Sophie M. Lanzkron, MD, Jane A. Little, MD Chronic Kidney Disease Is UnderScreened in SCD and Mild Albuminuria Is Associated with a Drop in Hemoglobin: A Report from the Grndad Sickle Cell Registry. Blood (2019) 134 (Supplement_1): 2284. https://doi.org/10.1182/blood-2019-124933
11. Samuel R. Wilson,Matthew Sears,Elizabeth Williams,Jesse Drapekin,Ishwarya Sivakumar,Susan Padrino,Payal C. Desai,Ward Hager,Deepa Manwani, E. Leila J. Clay,Joshua J. Field,Julie Kanter,Alice J. Cohen,Sana Saif Ur Rehman,Sophie Lanzkron,Jane A. Little,the GRNDaD investigators, Gaps in the diagnosis and management of iron overload in sickle cell disease: a ‘real-world’ report from the GRNDaD registry. BJH (2021) August 22, 2021 http://doi.org/10.1111/bjh.17762
12. Study Biree Andemariam, MD1 ; Ifeyinwa Osunkwo, MD2; Modupe Idowu, MD3; Nirmish Shah, MD4; Richard Drachtman, MD5; Archana Sharma, DO5; Alexander Glaros, MD6; Maureen Achebe MD, MPH7; Alecia Nero, MD8; E. Leila Jerome Clay, MD, MCTS9; Susanna Curtis, MD10; Caterina Minniti Real-World Experience of Patients with Sickle Cell Disease Treated with Voxelotor: A Multicenter, Retrospective
13. Ofelia Alvarez, Sandra Echenique, E Leila Jerome Clay, Hector Rodriguez-Cortes, Thomas J Harrington, Mildred E Berry, Mary Murph, Christopher Wells, Cheryl Courtlandt, Laura Noonan Successful Quality Improvement Projects to Maximize Prescription Rates and Acceptance of Hydroxyurea Among Patients with Sickle Cell Anemia November 2021, American Society of Hematology, Abstract #2983
14. E. Leila Jerome Clay, MD, MCTS1,2 , Carrie Gann, DNP, CPNP-PC1, Kyle Jordan, BSN, RN, BMT-CN1, Ashley Howard, MSN, APRN1, Dawn Gates, RN, CPN1 and Lorilyn Wilson, LCSW1 Implementation of an Education Curriculum for Adolescents and Young Adults with Sickle Cell Disease November 2021, American Society of Hematology
15. E Leila Jerome Clay, MD, MCTS1,2, Seethal A. Jacob, MD, MS3, Alexander Glaros, MD4 From One to Four: How and When I Use the Approved Medications for SCD November 2021, American Society of Hematology
Review Articles [RA]
1. Guillain-Barre Syndrome complicating multiple myeloma” Iqbal, Q. Le, R. Motiwala, L. Clay, T. Motiwala, N. Lendvai, D. Siegel, S. Goldberg. Blood (ASH Annual Meeting Abstracts), Nov 2008; 112: 5135
2. The Vitamin D Receptor Gene and Disease Severity in Sickle Cell Anemia. E. Leila Jerome Clay, MD, Janelle Hoskins, PhD, Alison Motsinger-Reif, PhD, Lindsay Veit, MD, David Barrow, DDS, Ali Calikoglu, MD, Rupa Redding-Lallinger, MD. Blood (2011) 118 (21): 2122. DOI: https://doi.org/10.1182/blood.V118.21.2122.2122
3. E. Leila Jerome Clay, MD, Julia Brittain, PhD, Rupa Redding-Lallinger, MD Blood (2012) 120 (21): 4768.
Vitamin Deficiency, CD40L and VEGF in a Young Population with Sickle Cell Disease DOI: https://doi.org/10.1182/blood.V120.21.4768.4768
4. Arati Rani Chand, MBBS, Hongyan Xu, PhD, Leigh G Wells, MSN, RN, FNP-BC, Betsy Clair, Cindy Neunert, MD MSCS, Alison E Spellman, MD, Leila Jerome Clay, MD, Kavita Natrajan, MBBS, Abdullah Kutlar, MD Are There True Non-Responders to Hydroxyurea in Sickle Cell Disease? a Multiparameter Analysis Blood (2014) 124 (21): 4073. DOI: https://doi.org/10.1182/blood.V124.21.4073.4073
5. Mary K Lintel, Latanya Bowman, Xu Hongyan, Abdullah Kutlar, Ryan A Harris, E. Leila Jerome Clay. A Pilot Study of Vitamin D Repletion Shows Improvement in Pain and Vascular Endothelial Function in Adult Patients with Sickle Cell Disease. Blood (2015) 126 (23): 4589. DOI: https://doi.org/10.1182/blood.V126.23.4589.4589
6. Amauri Bowman, Sydney Taylor, Pritam Bora, Hongyan Xu, Leigh Wells, Latanya Bowman, Nadine Barrett, Richard Lottenberg, E. Leila Jerome Clay, Betty Pace, Matthew Lyon, Robert Gibson, Abdullah Kutlar. Demographic Features of a Mixed Urban/Rural Adult Sickle Cell Population: Opportunities and Challenges for Improving Health Care. Blood 2015 126:5594
7. Michael Pope, Camila Albo, Kyle Michael Kidwell, Hongyan Xu, Latanya Bowman, Leigh Wells, Nadine Barrett, Sabine Fields, Pritam Bora, E. Leila Jerome Clay, Niren Patel and Abdullah Kutlar. Evolution of Chronic Pain in Sickle Cell Disease. Blood (2016) 128 (22): 1297. https://doi.org/10.1182/blood.V130.Suppl_1.443.443
8. Julia Brittain, E. Leila Jerome Clay, Ryan Harris, Itia Lee, Abdullah Kutlar and Sanjiv Kumar. Vitamin D Repletion Mitigates Oxidative Stress Induce Pulmonary Artery Remodeling in Sickle Cell
Disease Blood 2017 130:443 https://doi.org/10.1182/blood.V130.Suppl_1.443.443
9. Ofelia A. Alvarez, MD, Sandra Echenique, Hector Rodriguez-Cortes, MD, Thomas J. Harrington, MD, E. Leila Jerome Clay, MD MCTS, FAAP, Vandy Black, MD MSc, Mary Murph, Christopher Wells, Ifeyinwa Osunkwo, MDMPH, Blood (2019) 134 (Supplement_1): 5862. https://doi.org/10.1182/blood-2019-123215
Case Reports [CR]
1. Edwards A, Clay EL, Jewells V, Adams S, Crawford RD, Redding-Lallinger R. A 19-year- old man with sickle cell disease presenting with spinal infarction: a case report. J Med Case Rep. 2013: 7(1):210.
2. Diana Fridlyand, Caroline Wilder, E. Leila Jerome Clay, Bruce Gilbert, Betty S. Pace. Stroke in a child with hemoglobin SC disease: a case report describing use of hydroxyurea after transfusion therapy. Pediatric Reports 2017; 9:6984
Abstracts
1. Spinal Infarction in Sickle Cell Disease, a rare and Unexplained Complication. April Edwards, MD, E.
Leila Jerome Clay, Valerie Jewells, Regina Crawford, Rupa Redding- Lallinger. AJH (Foundation of
Sickle Cell Disease Research, April 2013)
2. A review of vitamin D deficiency, treatment and patient knowledge among patients with sickle cell disease and Parents. E. Leila Jerome Clay, Elizabeth Robinson, Rupa Redding- Lallinger. AJH (Foundation of Sickle Cell Disease Research, April 2013)
3. Arati Chand, MBBS, Hongyan Xu, PhD, Betsy Clair, Leila Clay, MD, Leigh Wells, RN, FNP, Kavita Natarajan, MBBS, Abdullah Kutlar, MD Hydroxyurea in Sickle Cell Disease: Lack of Response or Non Compliance? (Foundation of Sickle Cell Disease Research, April 2014)
4. Nadirah El Amin, Robert Gibson, E. Leila Jerome Clay, Cindy Neunert. Hydroxyurea Delivery: A survey of primary care providers (Foundation of Sickle Cell Disease Research, April 2015)
5. High dose vitamin D repletion improves vascular endothelial function in patients with Sickle Cell Disease. E. Leila Jerome Clay, Benjamin Sookhoo, Latanya Bowman, Hongyan Xu, Abdullah Kutlar, Ryan A. Harris (Foundation of Sickle Cell Disease Research, April 2015)
6. Caroline Wilder, Nisha George, Hongyan Xu, Leila Jerome Clay Sickle Cell Disease Transition Assessment and Readiness: A Baseline Analysis. Journal of Sickle Cell Disease and Hemoglobinopathy, Volume III April 15, 2016
7. Wilder C, George, N, Xu H, Ferris M, Jerome Clay, EL. (2017) Sickle Cell Disease Transition Assessment and
Readiness: Baseline vs. Post-Intervention Analysis. Oral presentation at the 11th Annual Sickle Cell Disease Research and Educational Symposium and 40th National Sickle Cell Disease Scientific Meeting; 2017 Apr; Ft. Lauderdale, FL
8 Leila Jerome Clay, Miranda Bailey, Dan Drozd, Jincy Paulose, Nicholas Ramscar, Kieran Mace,3 David Wormser . A Patient-Centric Approach to Improve the Understanding of Sickle Cell Disease Using Real-World Data ASH 2020 Oral and Poster Abstracts
Media Releases or Interviews [MR]
1. The Growing Concern about Vitamin D Deficiency, Lucy Adams, Augusta The Magazine of Metropolitan Augusta, October 2014 Issue
2. Go Girl by Karin Calloway, Augusta Family Magazine, May/June 2015 Issue
3. E. Leila Jerome Clay, What is Sickle Cell Disease? Tampa Bay Magazine, September 1, 2020 Issue
Other Media [OM] (Videos, Websites, Blogs, Social Media, etc.)
1. https://www.hopkinsallchildrens.org/ACH-News/Moments/Pulling-the-Community-Together-toHelp-the-Kids
2. https://www.hopkinsallchildrens.org/ACH-News/General-News/Fulfilling-a-Destiny
3. https://www.baynews9.com/fl/tampa/news/2020/03/30/everyday-hero--doctor-on-the-front-lines-insickle-cell-fight
4. https://www.tampabayparenting.com/article/what-is-sickle-cell-disease/ (Published/Aired on: September 2) – Leila Jerome Clay, MD, MCTS, medical director of the comprehensive sickle cell program at Johns Hopkins All Children’s Hospital, explains what the disease is, who it affects and clears up some common misconceptions in honor of Sickle Cell Disease Awareness Month.
5. https://www.statnews.com/2020/09/03/millions-carry-sickle-cell-trait-could-they-be-at-risk-for-severe-covid19/ (Published/Aired on: September 3) – E. Leila Jerome Clay, a pediatrician who directs the sickle cell program at Johns Hopkins All Children’s Hospital, said anyone who has the trait, or suspects they may have it because of family history of the disease, should take extra precautions to prevent exposing themselves to the virus.
6. http://archive.tveyes.com/18120/3629655-36392/c35f1a2a-ad00-4e8b-8338-2147ac728af6/BN9_09-23-2020_07.35.08.mp4
7. What Is Sickle Cell Disease? (Published/Aired on: September 23) – So what is sickle cell disease? We asked John Hopkins All Children’s Hospital Sickle Cell program director, Leila Jerome Clay, M.D.
8. https://www.wtsp.com/article/news/health/coronavirus/doctor-diaries-pediatric-physicians-treating-kids-with-covid-19/67-3790c2e6-f05c-4520-a1d1-c201645dd99c
9. https://www.fox13news.com/news/covid-diaries-treating-patients-on-the-pediatric-front-lines
10. https://www.hopkinsallchildrens.org/ACH-News/General-News/Dr-Leila-Jerome-Clay-Stays-In-Tune-with-Patients
11. https://www.hopkinsallchildrens.org/ACH-News/General-News/Sickle-Cell-Disease-Experts-Help-Siblings-Pursue-D
Disclosure information not submitted.
Sunday, June 18, 2023
4:15 PM – 4:30 PM East Coast USA Time